Market Cap

Adaptimmune Therapeutics plc Market Capitalization:

$311.8 Million

USD as of July 1, 2024

business Adaptimmune Therapeutics plc Company Profile

Adaptimmune Therapeutics plc Main Stock Listing

NASDAQ: ADAP

Market Capitalization History of Adaptimmune Therapeutics plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Adaptimmune Therapeutics plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 $199.9 M -34.76%
Jan. 1, 2023 $306.4 M -40.07%
Jan. 1, 2022 $511.2 M -46.52%
Jan. 1, 2021 $955.8 M 40.00%
Jan. 1, 2020 $682.7 M -19.92%
Jan. 1, 2019 $852.6 M -43.57%
Jan. 1, 2018 $1.51 B 100.23%
Jan. 1, 2017 $754.5 M -39.04%
Jan. 1, 2016 $1.24 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Adaptimmune Therapeutics plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Adaptimmune Therapeutics plc has the following listings and related stock indices.


Stock: NASDAQ: ADAP

Stock: FSX: 473A

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.